Clinical Trials and Registries

The WATCHMAN clinical program consists of five studies (initial pilot study, two randomized clinical trials (PROTECT AF and PREVAIL), the ASAP registry and the CAP and CAP 2 registries) which included more than 2400 patients and nearly 6000 patient-years of clinical evidence specific to the WATCHMAN LAAC Device.

WATCHMAN clinical program consists of five studies which include more than 2400 patients and nearly 6000 patient-years. WATCHMAN clinical program consists of five studies which include more than 2400 patients and nearly 6000 patient-years.